Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    6815536 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia
Condition: Adult T-Cell Leukemia (ATL)
Interventions: Drug: LMB-2;   Drug: Fludarabine;   Drug: Cyclophosphamide

Study has passed its completion date and status has not been verified in more than two years.